ORIGINAL RESEARCH
Published on 24 Dec 2021
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
doi 10.3389/fphar.2021.778781
- 2,546 views
- 4 citations
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- Colorectal Cancer: Targets, Treatment and Prevention
Colorectal Cancer: Targets, Treatment and Prevention
23k
Total downloads
76k
Total views and downloads
Articles
REVIEW
Published on 23 Dec 2021
Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
doi 10.3389/fphar.2021.757120
- 9,105 views
- 48 citations
REVIEW
Published on 23 Nov 2021
The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
doi 10.3389/fphar.2021.768861
- 6,776 views
- 35 citations
REVIEW
Published on 22 Nov 2021
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer
doi 10.3389/fphar.2021.758320
- 3,021 views
- 6 citations
ORIGINAL RESEARCH
Published on 01 Nov 2021
Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma
doi 10.3389/fphar.2021.739501
- 2,813 views
- 7 citations
MINI REVIEW
Published on 20 Oct 2021
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
doi 10.3389/fphar.2021.772101
- 14,601 views
- 84 citations
REVIEW
Published on 30 Sep 2021
Microbiota and Colorectal Cancer: From Gut to Bedside
doi 10.3389/fphar.2021.760280
- 8,900 views
- 34 citations
ORIGINAL RESEARCH
Published on 23 Sep 2021
Exosome-Derived ADAM17 Promotes Liver Metastasis in Colorectal Cancer
doi 10.3389/fphar.2021.734351
- 3,297 views
- 39 citations
ORIGINAL RESEARCH
Published on 17 Sep 2021
Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer
doi 10.3389/fphar.2021.725583
- 6,807 views
- 51 citations
PERSPECTIVE
Published on 07 Sep 2021
Perspective of Human Condensins Involved in Colorectal Cancer
doi 10.3389/fphar.2021.664982
- 1,299 views
- 2 citations
![Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives](https://www.frontiersin.org/files/myhome article library/691234/691234_Thumb_400.jpg)
ORIGINAL RESEARCH
Published on 27 Aug 2021
Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives
doi 10.3389/fphar.2021.691234
- 3,839 views
- 26 citations
